- Report
- September 2018
- 19 Pages
Global
From €9562EUR$10,000USD£8,194GBP
- Report
- January 2024
- 89 Pages
Global
From €3500EUR$3,921USD£3,104GBP
- Report
- January 2021
- 136 Pages
China, Global
From €3000EUR$3,361USD£2,661GBP
Aztreonam is an antibiotic used to treat a variety of bacterial infections. It belongs to a class of antibiotics called monobactams, which are used to treat infections caused by gram-negative bacteria. Aztreonam is effective against a wide range of bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. It is often used in combination with other antibiotics to treat more serious infections. Aztreonam is available in both intravenous and intramuscular forms, and is often used in hospital settings.
Aztreonam is a widely used antibiotic in the medical community, and is often prescribed for the treatment of serious infections. It is generally well tolerated, with few side effects. It is also relatively inexpensive, making it an attractive option for many patients.
Some companies in the Aztreonam market include GlaxoSmithKline, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more